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Dear Editor,
Tumors originating in the digestive system, like those in other areas, whether solid or otherwise, may present with a paraneoplastic syndrome.
Systemic lupus erythematosus (SLE) is an autoimmune condition that sometimes represents a paraneoplastic manifestation heralding a primary tumor (1).
Case report
A 70-year-old male diagnosed with SLE a year ago, who was initially screened with serologic, endoscopic, and imaging tests to rule out an associated neoplasm with negative results, presents 11 months later with jaundice and renal function impairment. Ultrasounds reveal a dilated bile duct with a 17-mm choledochus. A combined magnetic resonance imaging (MRI) and cholangioresonance (MRC) procedure shows the cause to be a distal 2-cm stop suggestive of cholangiocarcinoma.
Combined MRI and MRC have proven to be effective for the study of liver parenchyma with ductal and vascular involvement (2) . A thoracoabdominal CT scan revealed no other findings and the workup was deemed completed, hence no endoscopy was carried out. A multidisciplinar committee decided to perform a cephalic duodeno-pancreatectomy procedure after ERCP, with stent placement to improve renal function. The diagnosis of cholangiocarcinoma was confirmed on the surgical specimen.
Discussion
A diagnosis of lupus may precede that of a tumor by up to 5 years, although primary tumors are most commonly diagnosed within one year after SLE diagnosis. Considering the prolonged subclinical period a tumor may have, SLE has been posited as a paraneoplastic syndrome that may precede cancer (1).
While paraneoplastic and autoimmune manifestations have been reported in patients with cholangiocarcinoma, the latter association with lupus is exceptional (3). Neoplasms most commonly associated with lupus are those arising from blood components, followed by breast cancer (1).
To conclude, a biliopancreatic tumor and the paraneoplastic nature of SLE should be suspected even in the presence of negative initial testing.
